Saltar al contenido
Merck

Multidrug-resistant tuberculosis that required 2 years for diagnosis.

BMJ case reports (2012-05-19)
Shuichi Yano, Kanako Kobayashi, Toshikazu Ikeda
RESUMEN

Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent. Drug-resistant Mycobacterium tuberculosis strains are reported to be extremely difficult to cultivate invitro. The authors report a case of MDRTB that required 2 years for diagnosis, and was detected only in sputum culture on solid medium. Physicians should consider MDRTB if TB is suspected but pathogens are not detected.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
4-Aminosalicylic acid, 99%
Sigma-Aldrich
Sodium 4-aminosalicylate dihydrate, ≥97.0% (T)